|
Valoración de DCF de Zimmer Biomet Holdings, Inc. (ZBH)
US | Healthcare | Medical - Devices | NYSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Zimmer Biomet Holdings, Inc. (ZBH) Bundle
Si es un inversor o analista, esta calculadora DCF [ZBH] es la herramienta perfecta para una valoración precisa. Equipado con datos reales de Zimmer Biomet Holdings, Inc., puede ajustar previsos e inmediatamente observar los efectos.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7,982.2 | 7,024.5 | 6,827.3 | 6,939.9 | 7,394.2 | 7,272.0 | 7,151.8 | 7,033.7 | 6,917.4 | 6,803.1 |
Revenue Growth, % | 0 | -12 | -2.81 | 1.65 | 6.55 | -1.65 | -1.65 | -1.65 | -1.65 | -1.65 |
EBITDA | 2,395.0 | 969.7 | 2,160.1 | 2,212.6 | 2,214.3 | 1,996.6 | 1,963.6 | 1,931.1 | 1,899.2 | 1,867.8 |
EBITDA, % | 30 | 13.8 | 31.64 | 31.88 | 29.95 | 27.46 | 27.46 | 27.46 | 27.46 | 27.46 |
Depreciation | 1,006.1 | 1,032.7 | 937.7 | 926.4 | 951.7 | 978.2 | 962.1 | 946.2 | 930.5 | 915.2 |
Depreciation, % | 12.6 | 14.7 | 13.73 | 13.35 | 12.87 | 13.45 | 13.45 | 13.45 | 13.45 | 13.45 |
EBIT | 1,388.9 | -63.0 | 1,222.4 | 1,286.2 | 1,262.6 | 1,018.3 | 1,001.5 | 984.9 | 968.7 | 952.7 |
EBIT, % | 17.4 | -0.89686 | 17.9 | 18.53 | 17.08 | 14 | 14 | 14 | 14 | 14 |
Total Cash | 617.9 | 802.1 | 378.1 | 375.7 | 415.8 | 519.7 | 511.1 | 502.7 | 494.4 | 486.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 1,363.9 | 1,452.7 | 1,259.6 | 1,381.5 | 1,442.4 | 1,390.9 | 1,367.9 | 1,345.3 | 1,323.0 | 1,301.2 |
Account Receivables, % | 17.09 | 20.68 | 18.45 | 19.91 | 19.51 | 19.13 | 19.13 | 19.13 | 19.13 | 19.13 |
Inventories | 2,385.0 | 2,450.7 | 2,148.0 | 2,147.2 | 2,385.2 | 2,318.7 | 2,280.4 | 2,242.7 | 2,205.6 | 2,169.2 |
Inventories, % | 29.88 | 34.89 | 31.46 | 30.94 | 32.26 | 31.89 | 31.89 | 31.89 | 31.89 | 31.89 |
Accounts Payable | 400.9 | 330.0 | 306.5 | 354.1 | 410.6 | 361.6 | 355.7 | 349.8 | 344.0 | 338.3 |
Accounts Payable, % | 5.02 | 4.7 | 4.49 | 5.1 | 5.55 | 4.97 | 4.97 | 4.97 | 4.97 | 4.97 |
Capital Expenditure | -404.7 | -117.9 | -152.0 | -187.9 | -602.8 | -288.5 | -283.7 | -279.0 | -274.4 | -269.9 |
Capital Expenditure, % | -5.07 | -1.68 | -2.23 | -2.71 | -8.15 | -3.97 | -3.97 | -3.97 | -3.97 | -3.97 |
Tax Rate, % | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 |
EBITAT | 1,735.1 | -31.5 | 983.8 | 737.6 | 1,211.4 | 781.8 | 768.8 | 756.1 | 743.6 | 731.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -1,011.5 | 657.9 | 2,241.8 | 1,402.6 | 1,317.9 | 1,540.6 | 1,502.5 | 1,477.7 | 1,453.3 | 1,429.3 |
WACC, % | 8.25 | 7.78 | 8.07 | 7.85 | 8.21 | 8.03 | 8.03 | 8.03 | 8.03 | 8.03 |
PV UFCF | ||||||||||
SUM PV UFCF | 5,923.4 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 1,486 | |||||||||
Terminal Value | 36,849 | |||||||||
Present Terminal Value | 25,040 | |||||||||
Enterprise Value | 30,963 | |||||||||
Net Debt | 5,579 | |||||||||
Equity Value | 25,384 | |||||||||
Diluted Shares Outstanding, MM | 210 | |||||||||
Equity Value Per Share | 121.05 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator with pre-filled real ZBH financials.
- Real-World Data: Historical data and forward-looking estimates (as shown in the yellow cells).
- Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Zimmer Biomet's valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, accompanied by step-by-step instructions.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Zimmer Biomet Holdings, Inc. (ZBH).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs for precise calculations.
- Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates to fit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Zimmer Biomet Holdings, Inc. (ZBH).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the prebuilt Excel template containing Zimmer Biomet's data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view the updated results, including Zimmer Biomet's intrinsic value.
- Step 5: Utilize the outputs to make informed investment decisions or create reports.
Why Choose This Calculator for Zimmer Biomet Holdings, Inc. (ZBH)?
- Designed for Industry Experts: A sophisticated tool tailored for healthcare analysts, financial officers, and consultants.
- Accurate Financial Data: Zimmer Biomet’s historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use This Product?
- Investors: Accurately assess Zimmer Biomet's fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to ZBH.
- Consultants: Easily customize the template for valuation reports tailored to clients interested in Zimmer Biomet.
- Entrepreneurs: Acquire insights into financial modeling techniques employed by leading healthcare companies.
- Educators: Implement it as a teaching resource to illustrate valuation methodologies in finance courses.
What the Template Contains
- Historical Data: Includes Zimmer Biomet's past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Zimmer Biomet's intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Zimmer Biomet's financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.